• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芳基烃受体介导 Jak2/STAT3 信号通路促进非小细胞肺癌干细胞的自我更新。

Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.

机构信息

Department of Pulmonary Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China; Department of Immunology, Fourth Military Medical University, Xi'an, 710032, China.

Department of Pulmonary Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.

出版信息

Exp Cell Res. 2020 Nov 1;396(1):112288. doi: 10.1016/j.yexcr.2020.112288. Epub 2020 Sep 14.

DOI:10.1016/j.yexcr.2020.112288
PMID:32941808
Abstract

Cancer stem cells (CSCs) play an important role in shaping the invasive cancer phenotype by contributing to tumor initiation, metastasis, relapse, and therapeutic resistance in non-small cell lung cancer (NSCLC). The Aryl hydrocarbon receptor (AhR), a ligand activated transcription factor, which is well known for mediating the toxicity and tumorigenesis of a variety of environmental pollutants, has been extensively recognized as an important mediator in NSCLC development. Here, evidence showed that AhR was overexpressed in NSCLC tissues, and a high AhR protein level was associated with an aggressive tumor phenotype. Knockdown of AhR suppressed cell proliferation, invasion and migration, as well as CSC-like properties, while upregulation and activation of AhR enhanced CSC-like properties and increased stem cell-associated gene expression in NSCLC cells. Elevated and activated AhR leads to phosphorylation of janus kinase 2 (Jak2), as well as its downstream effector, activator of transcription 3 (STAT3), while inhibition of Jak2/STAT3 signaling by pharmacologic approach attenuates the effects of AhR-mediated NSCLC cell stemness, suggesting a role for the Jak2/STAT3 pathway in AhR-regulated NSCLC stemness. In summary, our study uncovers a transcriptional-independent mechanism of AhR through which AhR mediates NSCLC stemness via Jak2/STAT3 signaling pathway, indicating a promising target for the treatment of NSCLC.

摘要

癌症干细胞 (CSCs) 通过促进非小细胞肺癌 (NSCLC) 的肿瘤起始、转移、复发和治疗抵抗,在塑造侵袭性癌症表型方面发挥着重要作用。芳香烃受体 (AhR) 是一种配体激活的转录因子,它以介导多种环境污染物的毒性和肿瘤发生而闻名,已被广泛认为是 NSCLC 发展的重要介质。在这里,有证据表明 AhR 在 NSCLC 组织中过度表达,并且 AhR 蛋白水平高与侵袭性肿瘤表型相关。AhR 的敲低抑制了细胞增殖、侵袭和迁移以及 CSC 样特性,而 AhR 的上调和激活增强了 CSC 样特性,并增加了 NSCLC 细胞中与干细胞相关的基因表达。升高和激活的 AhR 导致 Janus 激酶 2 (Jak2) 及其下游效应物转录激活因子 3 (STAT3) 的磷酸化,而通过药理学方法抑制 Jak2/STAT3 信号通路减弱了 AhR 介导的 NSCLC 细胞干性的作用,表明 Jak2/STAT3 通路在 AhR 调节的 NSCLC 干性中起作用。总之,我们的研究揭示了 AhR 的一种转录非依赖性机制,通过该机制,AhR 通过 Jak2/STAT3 信号通路介导 NSCLC 干性,表明这是治疗 NSCLC 的有希望的靶点。

相似文献

1
Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.芳基烃受体介导 Jak2/STAT3 信号通路促进非小细胞肺癌干细胞的自我更新。
Exp Cell Res. 2020 Nov 1;396(1):112288. doi: 10.1016/j.yexcr.2020.112288. Epub 2020 Sep 14.
2
Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling.芳香烃受体的激活通过激活Src 介导的旁路信号导致非小细胞肺癌对 EGFR TKI 的耐药性。
Clin Cancer Res. 2018 Mar 1;24(5):1227-1239. doi: 10.1158/1078-0432.CCR-17-0396. Epub 2017 Dec 11.
3
Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4.配体非依赖性芳烃受体通过降解Smad4抑制肺癌细胞侵袭。
Cancer Lett. 2016 Jul 1;376(2):211-7. doi: 10.1016/j.canlet.2016.03.052. Epub 2016 Apr 6.
4
PGRMC1 promotes NSCLC stemness phenotypes by disrupting TRIM56-mediated ubiquitination of AHR.PGRMC1 通过破坏 TRIM56 介导的 AHR 泛素化来促进 NSCLC 干性表型。
Biochim Biophys Acta Mol Basis Dis. 2024 Oct;1870(7):167440. doi: 10.1016/j.bbadis.2024.167440. Epub 2024 Jul 24.
5
C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer.C-X-C 趋化因子受体 2 通过激活非小细胞肺癌中的 JAK2/STAT3 通路与不良预后相关,并促进恶性细胞活动。
Cell Cycle. 2019 Dec;18(24):3456-3471. doi: 10.1080/15384101.2019.1689471. Epub 2019 Nov 15.
6
Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.芳烃受体/细胞色素P450 1A1途径通过抑制PTEN以及激活β-连环蛋白和Akt介导乳腺癌干细胞的扩增。
Mol Cancer. 2017 Jan 19;16(1):14. doi: 10.1186/s12943-016-0570-y.
7
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR.人类癌症中组成型吲哚胺2,3-双加氧酶(IDO)的表达由一个涉及白细胞介素-6(IL-6)、信号转导和转录激活因子3(STAT3)以及芳香烃受体(AHR)的自分泌信号回路维持。
Oncotarget. 2014 Feb 28;5(4):1038-51. doi: 10.18632/oncotarget.1637.
8
Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).芳烃受体(AHR)是一种新型可药物治疗的途径,可控制慢性髓性白血病(CML)中恶性祖细胞的增殖。
PLoS One. 2018 Aug 9;13(8):e0200923. doi: 10.1371/journal.pone.0200923. eCollection 2018.
9
Benzo(a)pyrene regulated A549 cell migration, invasion and epithelial-mesenchymal transition by up-regulating long non-coding RNA linc00673.苯并(a)芘通过上调长链非编码 RNA linc00673 调控 A549 细胞迁移、侵袭和上皮-间充质转化。
Toxicol Lett. 2020 Mar 1;320:37-45. doi: 10.1016/j.toxlet.2019.11.024. Epub 2019 Nov 25.
10
A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.樟芝中的一种倍半萜内酯化合物——antrocin 通过 microRNA let-7c 负向调控 JAK2/STAT3 信号通路,诱导肺癌细胞凋亡。
Carcinogenesis. 2013 Dec;34(12):2918-28. doi: 10.1093/carcin/bgt255. Epub 2013 Jul 23.

引用本文的文献

1
Connection between circulating inflammatory cytokines and non-small cell lung cancer: integrated Mendelian randomization and gene function analysis.循环炎症细胞因子与非小细胞肺癌之间的关联:孟德尔随机化与基因功能综合分析
Discov Oncol. 2025 Jun 4;16(1):1005. doi: 10.1007/s12672-025-02817-4.
2
Targeting the Kynurenine Pathway: A Novel Approach in Tumor Therapy.靶向犬尿氨酸途径:肿瘤治疗的新方法。
Expert Rev Mol Med. 2025 Mar 5;27:1-33. doi: 10.1017/erm.2025.5.
3
Bioluminescence imaging of Cyp1a1-luciferase reporter mice demonstrates prolonged activation of the aryl hydrocarbon receptor in the lung.
Cyp1a1-荧光素酶报告基因小鼠的生物发光成像显示,芳烃受体在肺部的激活时间延长。
Commun Biol. 2024 Apr 10;7(1):442. doi: 10.1038/s42003-024-06089-6.
4
KDF1 Promoted Proliferation, Migration and Invasion of Lung Adenocarcinoma Cells through Activating STAT3 and AKT Pathway.KDF1通过激活STAT3和AKT信号通路促进肺腺癌细胞的增殖、迁移和侵袭。
Biomedicines. 2023 Dec 1;11(12):3194. doi: 10.3390/biomedicines11123194.
5
Activation of Chaperone-Mediated Autophagy Inhibits the Aryl Hydrocarbon Receptor Function by Degrading This Receptor in Human Lung Epithelial Carcinoma A549 Cells.热休克蛋白介导的自噬通过降解人肺上皮癌细胞 A549 中的芳烃受体来抑制芳烃受体功能。
Int J Mol Sci. 2023 Oct 12;24(20):15116. doi: 10.3390/ijms242015116.
6
Role of Ubiquitination and Epigenetics in the Regulation of AhR Signaling in Carcinogenesis and Metastasis: "Albatross around the Neck" or "Blessing in Disguise".泛素化和表观遗传学在芳烃受体信号转导调控致癌和转移中的作用:“脖子上的累赘”还是“因祸得福”。
Cells. 2023 Sep 29;12(19):2382. doi: 10.3390/cells12192382.
7
From Nucleus to Organs: Insights of Aryl Hydrocarbon Receptor Molecular Mechanisms.从核到器官:芳香烃受体分子机制的见解。
Int J Mol Sci. 2022 Nov 29;23(23):14919. doi: 10.3390/ijms232314919.
8
MBL Binding with AhR Controls Th17 Immunity in Silicosis-Associated Lung Inflammation and Fibrosis.甘露聚糖结合凝集素(MBL)与芳烃受体(AhR)的结合调控矽肺相关肺部炎症和纤维化中的Th17免疫反应。
J Inflamm Res. 2022 Jul 28;15:4315-4329. doi: 10.2147/JIR.S357453. eCollection 2022.
9
VEGF-B targeting by aryl hydrocarbon receptor mediates the migration and invasion of choriocarcinoma stem-like cells.芳烃受体对血管内皮生长因子B的靶向作用介导了绒毛膜癌干细胞样细胞的迁移和侵袭。
Cancer Cell Int. 2022 Jun 30;22(1):221. doi: 10.1186/s12935-022-02641-8.
10
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation.吲哚胺 2,3-双加氧酶 1 介导慢性淋巴细胞白血病中的存活信号 犬尿氨酸/芳烃受体介导的 MCL1 调节。
Front Immunol. 2022 Mar 18;13:832263. doi: 10.3389/fimmu.2022.832263. eCollection 2022.